探地雷达
雌激素受体
雌激素
受体
雌激素受体
生物
内科学
内分泌学
医学
生物化学
乳腺癌
癌症
作者
Fujie Xu,Jie Ma,Xiaowu Wang,Xiaoya Wang,Wei-Yi Fang,Jing Sun,Zilin Li,Jincheng Liu
出处
期刊:Biomolecules
[MDPI AG]
日期:2023-09-19
卷期号:13 (9): 1410-1410
被引量:1
摘要
Objective: Estrogen is indispensable in health and disease and mainly functions through its receptors. The protection of the cardiovascular system by estrogen and its receptors has been recognized for decades. Numerous studies with a focus on estrogen and its receptor system have been conducted to elucidate the underlying mechanism. Although nuclear estrogen receptors, including estrogen receptor-α and estrogen receptor-β, have been shown to be classical receptors that mediate genomic effects, studies now show that GPER mainly mediates rapid signaling events as well as transcriptional regulation via binding to estrogen as a membrane receptor. With the discovery of selective synthetic ligands for GPER and the utilization of GPER knockout mice, significant progress has been made in understanding the function of GPER. In this review, the tissue and cellular localizations, endogenous and exogenous ligands, and signaling pathways of GPER are systematically summarized in diverse physiological and diseased conditions. This article further emphasizes the role of GPER in vascular pathology and physiology, focusing on the latest research progress and evidence of GPER as a promising therapeutic target in hypertension, pulmonary hypertension, and atherosclerosis. Thus, selective regulation of GPER by its agonists and antagonists have the potential to be used in clinical practice for treating such diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI